Table 3.
Crude outcome rates from symptom presentation to end of study follow-up
| Pathway | Included, n (%)* | Excluded, n (%) | Total, n (%) |
| Emergency admission for HF | |||
| 1. NICE recommendation (echo/NP and referral) | 558 (57.2) | 175 (96.2) | 727 (62.8) |
| 2. Guidance partially followed (echo/NP or referral) | 1810 (69.9) | 627 (96.3) | 2361 (72.9) |
| 3. Treatment only—HF medications but no NP/echo or referral | 4153 (81.2) | 1150 (97.6) | 5002 (79.5) |
| 4. No NP/echo, referral or HF medications | 4410 (84.6) | 572 (95.5) | 4881 (84.0) |
| Total HF admissions (overall rate as %) | 10 931 (78.7) | 2525 (96.7) | 12 971 (78.6) |
| Death | |||
| 1. NICE recommendation (echo/NP and referral) | 280 (28.7) | 64 (35.2) | 344 (29.7) |
| 2. Guidance partially followed (echo/NP or referral) | 914 (35.3) | 253 (38.9) | 1167 (36.0) |
| 3. Treatment only—HF medications but no NP/echo or referral | 2106 (41.2) | 536 (45.5) | 2642 (42.0) |
| 4. No NP/echo, referral or HF medications | 2287 (43.9) | 366 (61.1) | 2653 (45.6) |
| Total deaths (overall rate as %) | 5587 (40.2) | 1219 (46.7) | 6806 (41.2) |
*χ2 tests for trend across pathways: p<0.001 for both outcomes.
HF, heart failure; NICE, National Institute for Health and Care Excellence; NP, natriuretic peptide.